Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 404

1.

Development and reliability of a hand-held dynamometer device to measure the ankle dorsiflexor muscle strength.

Kimura M, Ogata Y, Akebi T, Ochi M, Hachisuka K, Saeki S.

J Rehabil Assist Technol Eng. 2018 Nov 18;5:2055668318802558. doi: 10.1177/2055668318802558. eCollection 2018 Jan-Dec.

PMID:
31191956
2.

Disorder of Coagulation-Fibrinolysis System: An Emerging Toxicity of Anti-PD-1/PD-L1 Monoclonal Antibodies.

Sato R, Imamura K, Sakata S, Ikeda T, Horio Y, Iyama S, Akaike K, Hamada S, Jodai T, Nakashima K, Ishizuka S, Sato N, Saruwatari K, Saeki S, Tomita Y, Sakagami T.

J Clin Med. 2019 May 29;8(6). pii: E762. doi: 10.3390/jcm8060762.

3.

Four-meter gait speed predicts daily physical activity in patients with chronic respiratory diseases.

Yoshida C, Ichiyasu H, Ideguchi H, Hirosako S, Masunaga A, Kojima K, Saeki S, Fujii K, Sakagami T, Kohrogi H.

Respir Investig. 2019 May 13. pii: S2212-5345(18)30221-1. doi: 10.1016/j.resinv.2019.03.009. [Epub ahead of print]

PMID:
31092319
4.

Characteristics and association with survival of respiratory-related hospitalization in Japanese idiopathic pulmonary fibrosis patients.

Nishiyama O, Saeki S, Yamazaki R, Sano H, Iwanaga T, Kume H, Tohda Y.

Respir Investig. 2019 Apr 16. pii: S2212-5345(18)30316-2. doi: 10.1016/j.resinv.2019.03.005. [Epub ahead of print]

PMID:
31003952
5.

Protective effect of bevacizumab on chemotherapy-related acute exacerbation of interstitial lung disease in patients with advanced non-squamous non-small cell lung cancer.

Hamada S, Ichiyasu H, Ikeda T, Inaba M, Kashiwabara K, Sadamatsu T, Sato N, Akaike K, Okabayashi H, Saruwatari K, Tomita Y, Saeki S, Hirata N, Yoshinaga T, Fujii K.

BMC Pulm Med. 2019 Apr 2;19(1):72. doi: 10.1186/s12890-019-0838-2.

6.

Upfront Cranial Radiotherapy Followed by Erlotinib Positively Affects Clinical Outcomes of Epidermal Growth Factor Receptor-mutant Non-small Cell Lung Cancer With Brain Metastases.

Saruwatari K, Ikeda T, Saeki S, Shingu N, Imamura K, Komatu T, Ushijima S, Maruyama H, Kashiwabara K, Tomita Y, Ichiyasu H, Fujii K, Sakagami T.

Anticancer Res. 2019 Feb;39(2):923-931. doi: 10.21873/anticanres.13195.

PMID:
30711977
7.

The Risks and Benefits of Immune Checkpoint Blockade in Anti-AChR Antibody-Seropositive Non-Small Cell Lung Cancer Patients.

Saruwatari K, Sato R, Nakane S, Sakata S, Takamatsu K, Jodai T, Mito R, Horio Y, Saeki S, Tomita Y, Sakagami T.

Cancers (Basel). 2019 Jan 24;11(2). pii: E140. doi: 10.3390/cancers11020140.

8.

Insights into the mechanism of paradoxical low-flow, low-pressure gradient severe aortic stenosis: association with reduced O2 consumption by the whole body.

Onoue T, Iwataki M, Araki M, Itoh H, Isotani A, Umeda H, Fukuda S, Nagata Y, Tsuda Y, Fujino Y, Hanyu M, Ando K, Shirai S, Takeuchi M, Saeki S, Levine RA, Otsuji Y.

Am J Physiol Heart Circ Physiol. 2019 Apr 1;316(4):H840-H848. doi: 10.1152/ajpheart.00715.2018. Epub 2019 Jan 25.

PMID:
30681367
9.

Exploration of germline variants responsible for adverse events of crizotinib in anaplastic lymphoma kinase-positive non-small cell lung cancer by target-gene panel sequencing.

Mizugaki H, Hamada A, Shibata T, Hosoda F, Nakamura H, Okuma Y, Shukuya T, Umemura S, Horiike A, Fukui T, Kogure Y, Daga H, Urata Y, Yamada K, Saeki S, Fujisaka Y, Nakamura Y, Sato M, Yoshida T, Hotta T, Oizumi S, Fujiwara Y, Ohe Y, Fujiwara Y.

Lung Cancer. 2019 Feb;128:20-25. doi: 10.1016/j.lungcan.2018.12.002. Epub 2018 Dec 4.

PMID:
30642448
10.

Acute Exacerbation of Idiopathic Interstitial Pneumonia in a Patient with Hepatocellular Carcinoma after Transcatheter Arterial Therapy Using Miriplatin.

Kakiuchi Y, Sakata S, Nakamura K, Okabayashi H, Akaike K, Tokunaga T, Saeki S, Fujii K, Ichiyasu H.

Intern Med. 2019 May 1;58(9):1329-1333. doi: 10.2169/internalmedicine.1446-18. Epub 2019 Jan 10.

11.

A potential mechanism of the onset of acute eosinophilic pneumonia triggered by an anti-PD-1 immune checkpoint antibody in a lung cancer patient.

Jodai T, Yoshida C, Sato R, Kakiuchi Y, Sato N, Iyama S, Kimura T, Saruwatari K, Saeki S, Ichiyasu H, Fujii K, Tomita Y.

Immun Inflamm Dis. 2019 Mar;7(1):3-6. doi: 10.1002/iid3.238. Epub 2018 Nov 21.

12.

Negative Impact of Coexisting Interstitial Lung Disease on Clinical Outcomes in Small-cell Lung Cancer Patients.

Akaike K, Saruwatari K, Okabayashi H, Hamada S, Jodai Y, Jodai T, Sakata S, Iyama S, Sato R, Iriki T, Tomita Y, Saeki S, Ichiyasu H, Fujii K.

Anticancer Res. 2018 Nov;38(11):6543-6550. doi: 10.21873/anticanres.13020.

PMID:
30396984
13.

Accuracy of objective tests for diagnosing adult asthma in symptomatic patients: A systematic literature review and hierarchical Bayesian latent-class meta-analysis.

Sano H, Tomita K, Sano A, Saeki S, Nishikawa Y, Nishiyama O, Iwanaga T, Tohda Y.

Allergol Int. 2019 Apr;68(2):191-198. doi: 10.1016/j.alit.2018.08.013. Epub 2018 Oct 8.

14.

[Pharmacological and clinical profile of spinal muscular atrophy (SMA) therapeutic drug nusinersen (Spinraza®)].

Ohmura T, Saeki S, Ogiwara K, Tobita K, Ling Y, Torii S.

Nihon Yakurigaku Zasshi. 2018;152(3):147-159. doi: 10.1254/fpj.152.147. Japanese.

PMID:
30185733
15.

Respiratory evaluation of the risk for postoperative pulmonary complications in patients who preoperatively consulted pulmonologists: Studying both patients who underwent and who precluded planned surgery.

Hirosako S, Nakamura K, Hamada S, Sugahara K, Yoshida C, Saeki S, Kojima K, Okamoto S, Ichiyasu H, Fujii K, Kohrogi H.

Respir Investig. 2018 Nov;56(6):448-456. doi: 10.1016/j.resinv.2018.07.005. Epub 2018 Aug 23.

PMID:
30146353
16.

Effects of leuprorelin for the treatment of recurrent gynecological cancer by assessment including self-administered quality-of-life questionnaire.

Tsubamoto H, Ueda T, Inoue K, Isono-Nakata R, Saeki S, Kato Y, Shibahara H.

J Obstet Gynaecol Res. 2019 Jan;45(1):203-209. doi: 10.1111/jog.13784. Epub 2018 Aug 16.

PMID:
30117238
17.

Trousseau's syndrome triggered by an immune checkpoint blockade in a non-small cell lung cancer patient.

Horio Y, Takamatsu K, Tamanoi D, Sato R, Saruwatari K, Ikeda T, Nakane S, Nakajima M, Saeki S, Ichiyasu H, Fujii K, Tomita Y.

Eur J Immunol. 2018 Oct;48(10):1764-1767. doi: 10.1002/eji.201847645. Epub 2018 Jul 19.

PMID:
29981156
18.

Successful treatment by pembrolizumab in a patient with end-stage renal disease with advanced non-small cell lung cancer and high PD-L1 expression.

Ishizuka S, Sakata S, Yoshida C, Takaki A, Saeki S, Nakamura K, Fujii K.

Respir Investig. 2018 Jul;56(4):361-364. doi: 10.1016/j.resinv.2018.03.005. Epub 2018 May 10.

PMID:
29764752
19.

Lung abscess following bronchoscopy due to multidrug-resistant Capnocytophaga sputigena adjacent to lung cancer with high PD-L1 expression.

Migiyama Y, Anai M, Kashiwabara K, Tomita Y, Saeki S, Nakamura K, Okamoto S, Ichiyasu H, Fujii K, Kohrogi H.

J Infect Chemother. 2018 Oct;24(10):852-855. doi: 10.1016/j.jiac.2018.03.017. Epub 2018 Apr 25.

PMID:
29703650
20.

Current Ventilator and Oxygen Management during General Anesthesia: A Multicenter, Cross-sectional Observational Study.

Suzuki S, Mihara Y, Hikasa Y, Okahara S, Ishihara T, Shintani A, Morimatsu H, Sato A, Kusume S, Hidaka H, Yatsuzuka H, Okawa M, Takatori M, Saeki S, Samuta T, Tokioka H, Kurasako T, Maeda M, Takeuchi M, Hirasaki A, Kitaura M, Kajiki H, Kobayashi O, Katayama H, Nakatsuka H, Mizobuchi S, Sugimoto S, Yokoyama M, Kusudo K, Shiraishi K, Iwaki T, Komatsu T, Hirai Y, Sato T, Kimura M, Yasukawa T, Kimura M, Taniguchi M, Shimoda Y, Kobayashi Y, Tsukioki M, Manabe N, Ando E, Kosaka M, Tsukiji T, Tokura C, Asao Y, Sugiyama M, Seto K; Okayama Research Investigation Organizing Network (ORION) investigators.

Anesthesiology. 2018 Jul;129(1):67-76. doi: 10.1097/ALN.0000000000002181.

PMID:
29553985
21.

Severe interstitial pneumonia associated with anti-PD-1 immune checkpoint antibody after talc slurry pleurodesis.

Sakata S, Matsuoka Y, Kawahara K, Kakiuchi Y, Takaki A, Hirosue A, Yoshida R, Saeki S, Fujii K, Nakayama H.

Respir Investig. 2018 Mar;56(2):195-198. doi: 10.1016/j.resinv.2017.11.006. Epub 2017 Dec 21.

PMID:
29548660
22.

Immediate effects of exercise intervention on cancer-related fatigue.

Matsugaki R, Akebi T, Shitama H, Wada F, Saeki S.

J Phys Ther Sci. 2018 Feb;30(2):262-265. doi: 10.1589/jpts.30.262. Epub 2018 Feb 20.

23.

Reversible Restrictive Lung Disease in Pseudomesotheliomatous Carcinoma in a Lung Harboring a HER2-mutation.

Sakata S, Sakamoto Y, Takaki A, Ishizuka S, Saeki S, Fujii K.

Intern Med. 2018 Aug 1;57(15):2223-2226. doi: 10.2169/internalmedicine.9612-17. Epub 2018 Mar 9.

24.

Development of a simple driving simulator and determination of the reference range of normative performance.

Kato N, Saeki S, Okazaki T, Matsunaga K, Hachisuka K.

Brain Inj. 2018;32(5):644-651. doi: 10.1080/02699052.2018.1432889. Epub 2018 Feb 1.

PMID:
29388857
25.

Visualization of age-related vascular alterations in facial skin using optical coherence tomography-based angiography.

Hara Y, Yamashita T, Kikuchi K, Kubo Y, Katagiri C, Kajiya K, Saeki S.

J Dermatol Sci. 2018 Apr;90(1):96-98. doi: 10.1016/j.jdermsci.2017.11.018. Epub 2018 Jan 8. No abstract available.

PMID:
29373160
26.

Visualization of viscoelastic behavior in skin equivalent using optical coherence tomography-based straingraphy.

Hara Y, Ogura Y, Yamashita T, Furukawa D, Saeki S.

Skin Res Technol. 2018 May;24(2):334-339. doi: 10.1111/srt.12435. Epub 2018 Jan 24.

PMID:
29368351
27.

Population Pharmacokinetics and Adverse Events of Erlotinib in Japanese Patients with Non-small-cell Lung Cancer: Impact of Genetic Polymorphisms in Metabolizing Enzymes and Transporters.

Endo-Tsukude C, Sasaki JI, Saeki S, Iwamoto N, Inaba M, Ushijima S, Kishi H, Fujii S, Semba H, Kashiwabara K, Tsubata Y, Hayashi M, Kai Y, Saito H, Isobe T, Kohrogi H, Hamada A.

Biol Pharm Bull. 2018;41(1):47-56. doi: 10.1248/bpb.b17-00521.

28.

Long-term complete response to carboplatin plus paclitaxel combined with bevacizumab in a patient with metastatic spindle cell carcinoma.

Sakata S, Saeki S, Sato R, Ishizuka S, Sasaki J, Fujii K.

Respir Investig. 2017 Nov;55(6):372-375. doi: 10.1016/j.resinv.2017.08.005. Epub 2017 Oct 6.

PMID:
29153418
29.

A Favorable Response to Levetiracetam in a Patient with Metastatic Adenoid Cystic Carcinoma.

Sakata S, Saeki S, Terasaki Y, Natori Y, Fujii K.

Intern Med. 2018 Mar 1;57(5):721-724. doi: 10.2169/internalmedicine.9300-17. Epub 2017 Nov 20.

30.

The persistent inhibitory properties of saxagliptin on renal dipeptidyl peptidase-4: Studies with HK-2 cells in vitro and normal rats in vivo.

Uchii M, Sakai M, Hotta Y, Saeki S, Kimoto N, Hamaguchi A, Kitayama T, Kunori S.

J Pharmacol Sci. 2017 Nov;135(3):126-130. doi: 10.1016/j.jphs.2017.10.003. Epub 2017 Oct 23.

31.

Small-cell Lung Cancer Associated with SAPHO Syndrome.

Imamura K, Sakata S, Sakamoto Y, Saeki S.

Intern Med. 2018 Jan 1;57(1):149-151. doi: 10.2169/internalmedicine.9162-17. Epub 2017 Oct 16. No abstract available.

32.

The Reliability and Validity of the Japanese Version of the Stroke Impact Scale Version 3.0.

Ochi M, Ohashi H, Hachisuka K, Saeki S.

J UOEH. 2017;39(3):215-221. doi: 10.7888/juoeh.39.215. Japanese.

33.

Long-term survival of a patient with advanced gastric cancer with paraaortic lymph node metastasis who attained pathological complete response after S-1/CDDP chemotherapy: A case report.

Ushida Y, Hiramatsu K, Saeki S, Amemiya T, Goto H, Arai T.

Int J Surg Case Rep. 2017;39:260-263. doi: 10.1016/j.ijscr.2017.08.016. Epub 2017 Aug 18.

34.

Increased oxytocin-monomeric red fluorescent protein 1 fluorescent intensity with urocortin-like immunoreactivity in the hypothalamo-neurohypophysial system of aged transgenic rats.

Ohno S, Hashimoto H, Fujihara H, Fujiki N, Yoshimura M, Maruyama T, Motojima Y, Saito R, Ueno H, Sonoda S, Ohno M, Umezu Y, Hamamura A, Saeki S, Ueta Y.

Neurosci Res. 2018 Mar;128:40-49. doi: 10.1016/j.neures.2017.08.001. Epub 2017 Aug 30.

PMID:
28859972
35.

Acute coronary syndrome as a possible immune-related adverse event in a lung cancer patient achieving a complete response to anti-PD-1 immune checkpoint antibody.

Tomita Y, Sueta D, Kakiuchi Y, Saeki S, Saruwatari K, Sakata S, Jodai T, Migiyama Y, Akaike K, Hirosako S, Fujisue K, Yamamura S, Miyazaki S, Takashio S, Izumiya Y, Nakamura K, Tsujita K, Ichiyasu H, Fujii K.

Ann Oncol. 2017 Nov 1;28(11):2893-2895. doi: 10.1093/annonc/mdx326. No abstract available.

PMID:
28651328
36.

Effectiveness of workplace exercise supervised by a physical therapist among nurses conducting shift work: A randomized controlled trial.

Matsugaki R, Kuhara S, Saeki S, Jiang Y, Michishita R, Ohta M, Yamato H.

J Occup Health. 2017 Jul 27;59(4):327-335. doi: 10.1539/joh.16-0125-OA. Epub 2017 Jun 20.

37.

Poorly differentiated adenocarcinoma with signet-ring cells in duodenal papilla: a case report.

Ushida Y, Hiramatsu K, Saeki S, Amemiya T, Goto H, Arai T.

Surg Case Rep. 2017 Dec;3(1):14. doi: 10.1186/s40792-017-0287-1. Epub 2017 Jan 17.

38.
39.

Comparison of the Time Course of Return to Work After Stroke Between Two Cohort Studies in Japan.

Saeki S, Matsushima Y, Kato N, Itoh H, Shiraishi J.

J UOEH. 2016;38(4):311-315.

40.

Pulmonary Mucosa-associated Lymphoid Tissue Lymphoma with Spontaneous Regression after Computed Tomography-guided Needle Biopsy: A Case Report and Summary of 8 Reported Cases.

Fukushima K, Hirosako S, Tenjin Y, Mukasa Y, Kojima K, Saeki S, Okamoto S, Ichiyasu H, Fujii K, Kikukawa Y, Kawanaka K, Kohrogi H.

Intern Med. 2016;55(24):3655-3660. Epub 2016 Dec 15.

41.

Phase II trial of weekly nab-paclitaxel for previously treated advanced non-small cell lung cancer: Kumamoto thoracic oncology study group (KTOSG) trial 1301.

Sakata S, Saeki S, Okamoto I, Otsubo K, Komiya K, Morinaga R, Yoneshima Y, Koga Y, Enokizu A, Kishi H, Hirosako S, Yamaguchi E, Aragane N, Fujii S, Harada T, Iwama E, Semba H, Nakanishi Y, Kohrogi H.

Lung Cancer. 2016 Sep;99:41-5. doi: 10.1016/j.lungcan.2016.06.009. Epub 2016 Jun 14.

PMID:
27565912
42.

[Side Effects of Acetaminophen and their Management].

Saeki S.

Masui. 2016 Aug;65(7):701-708. Japanese.

PMID:
30358301
43.

Primary Diaphragmatic Dedifferentiated Liposarcoma in a Young Female Patient after Delivery.

Sakata S, Yoshida C, Saeki S, Hirosako S, Ichiyasu H, Kohrogi H.

Case Rep Oncol Med. 2016;2016:4042719. doi: 10.1155/2016/4042719. Epub 2016 May 10.

44.

A Case of Apoplexy Attack-Like Neuropathy due to Hereditary Neuropathy with Liability to Pressure Palsies in a Patient Diagnosed with Chronic Cerebral Infarction.

Hachisuka A, Matsushima Y, Hachisuka K, Saeki S.

J Stroke Cerebrovasc Dis. 2016 Jun;25(6):e83-5. doi: 10.1016/j.jstrokecerebrovasdis.2016.03.031. Epub 2016 Apr 11.

45.

An ex vivo study of photobiostimulation in the treatment of skin pathologies.

de Jesus PD, Saeki SI, Tedesco AC.

J Biophotonics. 2016 Dec;9(11-12):1189-1198. doi: 10.1002/jbio.201500288. Epub 2016 Mar 15.

PMID:
26992152
46.
47.

Development of wrist rehabilitation robot and interface system.

Yamamoto I, Matsui M, Inagawa N, Hachisuka K, Wada F, Hachisuka A, Saeki S.

Technol Health Care. 2015;24 Suppl 1:S27-32. doi: 10.3233/THC-151057.

PMID:
26409544
48.

Elevated serum IgG4 levels in two cases of paragonimiasis.

Saeki S, Horio Y, Hirosako S, Ichiyasu H, Fujii K, Kohrogi H.

Respirol Case Rep. 2015 Sep;3(3):92-4. doi: 10.1002/rcr2.110. Epub 2015 May 26.

49.

Gefitinib Combined With Standard Chemoradiotherapy in EGFR-Mutant Locally Advanced Non-Small-Cell Lung Cancer: The LOGIK0902/OLCSG0905 Intergroup Study Protocol.

Hotta K, Sasaki J, Saeki S, Takigawa N, Katsui K, Takayama K, Nogami N, Shioyama Y, Bessho A, Kishimoto J, Tanimoto M, Kiura K, Ichinose Y.

Clin Lung Cancer. 2016 Jan;17(1):75-9. doi: 10.1016/j.cllc.2015.08.004. Epub 2015 Aug 18.

PMID:
26387039
50.

Knockdown of the corazonin gene reveals its critical role in the control of gregarious characteristics in the desert locust.

Sugahara R, Saeki S, Jouraku A, Shiotsuki T, Tanaka S.

J Insect Physiol. 2015 Aug;79:80-7. doi: 10.1016/j.jinsphys.2015.06.009. Epub 2015 Jun 16.

PMID:
26092175

Supplemental Content

Support Center